| Structure and function of lipopolysaccharides C Erridge, E Bennett-Guerrero, IR Poxton Microbes and infection 4 (8), 837-851, 2002 | 952 | 2002 |
| Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection MH Wilcox, DN Gerding, IR Poxton, C Kelly, R Nathan, T Birch, ... New England Journal of Medicine 376 (4), 305-317, 2017 | 792 | 2017 |
| Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008 EJ Kuijper, F Barbut, JS Brazier, N Kleinkauf, T Eckmanns, ML Lambert, ... Eurosurveillance 13 (31), 18942, 2008 | 404 | 2008 |
| Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates F Barbut, P Mastrantonio, M Delmée, J Brazier, E Kuijper, I Poxton, ... Clinical Microbiology and Infection 13 (11), 1048-1057, 2007 | 389 | 2007 |
| Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome AS Goldie, KCH Fearon, JA Ross, GR Barclay, RE Jackson, IS Grant, ... Jama 274 (2), 172-177, 1995 | 370 | 1995 |
| Extensive DNA inversions in the B. fragilis genome control variable gene expression AM Cerdeño-Tárraga, S Patrick, LC Crossman, G Blakely, V Abratt, ... Science 307 (5714), 1463-1465, 2005 | 313 | 2005 |
| Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2 C Erridge, A Pridmore, A Eley, J Stewart, IR Poxton Journal of medical microbiology 53 (8), 735-740, 2004 | 258 | 2004 |
| The pathogenicity of Clostridium difficile IR Poxton, J McCoubrey, G Blair Clinical microbiology and infection 7 (8), 421-427, 2001 | 249 | 2001 |
| A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides FE Di Padova, H Brade, GR Barclay, IR Poxton, E Liehl, E Schuetze, ... Infection and immunity 61 (9), 3863-3872, 1993 | 246 | 1993 |
| Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling C Erridge, J Stewart, IR Poxton The Journal of experimental medicine 197 (12), 1787-1791, 2003 | 241 | 2003 |
| Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe EJ Kuijper, B Coignard, JS Brazier, C Suetens, D Drudy, C Wiuff, H Pituch, ... Eurosurveillance 12 (6), 1-2, 2007 | 218 | 2007 |
| Multidrug resistance in European Clostridium difficile clinical isolates P Spigaglia, F Barbanti, P Mastrantonio, ... Journal of antimicrobial chemotherapy 66 (10), 2227-2234, 2011 | 212 | 2011 |
| Bacterial cell surface techniques I Hancock, I Poxton Wiley & Sons, 1988 | 200 | 1988 |
| A European survey of diagnostic methods and testing protocols for Clostridium difficile F Barbut, M Delmée, JS Brazier, JC Petit, IR Poxton, M Rupnik, V Lalande, ... Clinical Microbiology and Infection 9 (10), 989-996, 2003 | 194 | 2003 |
| Endotoxin and nanobacteria in polycystic kidney disease JT Hjelle, MA Miller-Hjelle, IR Poxton, EO Kajander, N Ciftcioglu, ... Kidney international 57 (6), 2360-2374, 2000 | 175 | 2000 |
| Essentials of microbiology for dental students J Bagg, TW MacFarlane, IR Poxton, AJ Smith Oxford university press, 2005 | 165 | 2005 |
| Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis JA Windsor, KCH Fearon, JA Ross, GR Barclay, E Smyth, I Poxton, ... Journal of British Surgery 80 (8), 1042-1046, 1993 | 158 | 1993 |
| Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling C Erridge, OL Moncayo-Nieto, R Morgan, M Young, IR Poxton Journal of medical microbiology 56 (2), 165-171, 2007 | 153 | 2007 |
| Mucosa-associated bacterial flora of the human colon IR Poxton, R Brown, A Sawyerr, A Ferguson Journal of medical microbiology 46 (1), 85-91, 1997 | 152 | 1997 |
| Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes ML Hutchison, IR Poxton, JRW Govan Infection and immunity 66 (5), 2033-2039, 1998 | 151 | 1998 |
